[Can we stop the hepatitis C virus transmission in drug users?] - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique Année : 2006

[Can we stop the hepatitis C virus transmission in drug users?]

Résumé

Despite the effectiveness of drug treatment and harm reduction programmes aimed at reducing illegal drug use, especially heroin use, situations at risk of transmitting HCV infection are still very frequent. Among routes of drug administration, injection appears as the most dangerous mean regarding the spread of HCV infection among drug users. This practice frequently occurs within a context of a group sharing climate (equipment, substance, housing, etc.) and mutual support. Risk of unsafe behaviour is increased at the time of their first injection or during the first steps of their experience as newly injectors. Public health interventions should target a reduction in the number of injections by modifying the pharmacological format of sublingual buprenorphine, by defining the cessation of injection as one of the main objectives of drug users care programs, by designing and implementing interventions and iniatives that target recreational multiple drug users at risk of initiating drug injection.
Fichier non déposé

Dates et versions

inserm-00114020 , version 1 (15-11-2006)

Identifiants

  • HAL Id : inserm-00114020 , version 1
  • PUBMED : 17073131

Citer

France Lert. [Can we stop the hepatitis C virus transmission in drug users?]. Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2006, 54 Spec No 1, pp.1S61-1S67. ⟨inserm-00114020⟩
37 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More